These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6881089)

  • 1. Potential errors in the laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
    Harruff RC; Rohn RJ
    Am J Clin Pathol; 1983 Aug; 80(2):152-8. PubMed ID: 6881089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis.
    Rosse WF; Dourmashkin R; Humphrey JH
    J Exp Med; 1966 Jun; 123(6):969-84. PubMed ID: 5941785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells.
    Logue GL
    Blood; 1977 Aug; 50(2):239-47. PubMed ID: 17439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.
    Hänsch G; Hammer C; Jiji R; Rother U; Shin M
    Immunobiology; 1983 Mar; 164(2):118-26. PubMed ID: 6852860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria.
    Chow FL; Hall SE; Rosse WF; Telen MJ
    Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
    Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
    Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.
    Halperin JA; Nicholson-Weller A
    Complement Inflamm; 1989; 6(1):65-72. PubMed ID: 2650991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of some snake venoms in the diagnostics of paroxysmal nocturnal hemoglobinuria (PNH).
    Brabec V; Kornalík F; Zák J; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):293-302. PubMed ID: 2410338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.
    Aster RH; Enright SE
    J Clin Invest; 1969 Jul; 48(7):1199-210. PubMed ID: 5798625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane.
    Chow FL; Telen MJ; Rosse WF
    Blood; 1985 Oct; 66(4):940-5. PubMed ID: 4041621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome.
    Conrad ME; Barton JC
    Am J Hematol; 1979; 7(1):61-7. PubMed ID: 507047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human erythrocyte stromata on complement activation.
    Corrocher R; Tedesco F; Rabusin P; De Sandre G
    Br J Haematol; 1975 Feb; 29(2):235-41. PubMed ID: 33
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of paroxysmal nocturnal hemoglobinuria erythrocytes: increased lysis and lipid peroxide formation by hydrogen peroxide.
    Mengel CE; Kann HE; Meriwether WD
    J Clin Invest; 1967 Nov; 46(11):1715-23. PubMed ID: 6061745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.